Page last updated: 2024-10-25

clomipramine and Shock, Cardiogenic

clomipramine has been researched along with Shock, Cardiogenic in 1 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frustaci, A1
Ferilli, FA1
Chimenti, C1

Other Studies

1 other study available for clomipramine and Shock, Cardiogenic

ArticleYear
Hypersensitivity Myocarditis and Necrotizing Coronary Vasculitis by Clomipramine Causing Steroid-Sensitive Cardiogenic Shock.
    Circulation. Cardiovascular imaging, 2019, Volume: 12, Issue:2

    Topics: Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Clomipramine; Coronary Artery Disease; D

2019